CanSino Receives Another Strong Boost
Oct 09, 2024 19:29 HKT | |
|
GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis
Sep 25, 2024 21:00 HKT |  |
|
康哲藥業：磷酸蘆可替尼乳膏（白癜風）中國上市許可申請已獲受理
Sep 24, 2024 21:46 HKT |  |
|
Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management
Sep 17, 2024 20:30 HKT |  |
|
君聖泰醫藥亮相香港國際生物科技論壇
Sep 17, 2024 15:00 HKT |  |
|
君聖泰醫藥亮相香港國際生物科技論壇
Sep 16, 2024 14:53 HKT | |
|
君圣泰医药亮相香港国际生物科技论坛
Sep 13, 2024 18:22 HKT | |
|
EASD 2024 | 君圣泰医药口头报告熊去氧胆小檗碱（HTD1801）在T2DM中的两项事后分析
Sep 11, 2024 11:51 HKT | |
|
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies, Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801)
Sep 11, 2024 11:34 HKT | |
|
EASD 2024 | 君聖泰醫藥口頭報告熊去氧膽小檗碱（HTD1801）在T2DM中的兩項事後分析
Sep 11, 2024 11:16 HKT | |
|
Hua Medicine Announces 2024 Interim Results
Aug 30, 2024 11:40 HKT | |
|
華領醫藥公佈2024年中期業績
Aug 30, 2024 11:12 HKT | |
|
华领医药公布2024年中期业绩
Aug 30, 2024 09:25 HKT | |
|
CanSinoBIO Reports Outstanding H1 2024 Performance
Aug 29, 2024 22:23 HKT | |
|
康希諾生物2024上半年業績亮眼：流腦疫苗引領增長，加快合作與國際化步伐
Aug 29, 2024 22:17 HKT | |
|
康希诺生物2024上半年业绩亮眼：流脑疫苗引领增长，加快合作与国际化步伐
Aug 29, 2024 22:10 HKT | |
|
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna's COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1
Aug 24, 2024 08:00 HKT |  |
|
日本厚生勞動省批准了莫德納公司針對SARS-COV-2 JN.1變異株的COVID-19 mRNA疫苗的部分變更申請
Aug 24, 2024 08:00 HKT | |
|
日本厚生劳动省批准了莫德纳公司针对SARS-COV-2 JN.1变异株的COVID-19 mRNA疫苗的部分变更申请
Aug 24, 2024 08:00 HKT | |
|
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024
Aug 23, 2024 08:00 HKT |  |
|